Shanghai Henlius files HKEX next-day disclosure return, lifts share capital by 26,600 shares

• Shanghai Henlius Biotech filed a next-day disclosure return with Hong Kong Exchange on Aug. 25, 2026.
• Issued 26,600 new H shares in August, lifting total issued shares to 347,836,247 from 347,809,647.
• Issuances included 3,125 shares from exercised options under the 2025 H Share Share Option Scheme at HKD 50.25.
• Allocated 23,475 shares at RMB 1 to the trustee for the 2025 H Share Restricted Share Unit Scheme for future vesting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Henlius Biotech Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260825-12298249), on August 25, 2026, and is solely responsible for the information contained therein.